0000899243-22-029489.txt : 20220822 0000899243-22-029489.hdr.sgml : 20220822 20220822192733 ACCESSION NUMBER: 0000899243-22-029489 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220818 FILED AS OF DATE: 20220822 DATE AS OF CHANGE: 20220822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Murray CENTRAL INDEX KEY: 0001901077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39479 FILM NUMBER: 221184859 MAIL ADDRESS: STREET 1: 8300 W. SUNRISE BOULEVARD CITY: PLANTATION STATE: FL ZIP: 33322 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKUMIN INC. CENTRAL INDEX KEY: 0001776197 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8300 W SUNRISE BLVD CITY: PLANTATION STATE: FL ZIP: 33322 BUSINESS PHONE: 9546784489 MAIL ADDRESS: STREET 1: 8300 W SUNRISE BLVD CITY: PLANTATION STATE: FL ZIP: 33322 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-18 0 0001776197 AKUMIN INC. AKU 0001901077 Lee Murray C/O AKUMIN INC. 8300 W. SUNRISE BOULEVARD PLANTATION FL 33322 1 0 0 0 Common Stock 2022-08-18 4 P 0 2519 1.10 A 304511 D Common Stock 2022-08-18 4 P 0 6982 1.12 A 311493 D Common Stock 2022-08-18 4 P 0 1505 1.11 A 312998 D Common Stock 2022-08-18 4 P 0 453 1.13 A 313451 D Common Stock 2022-08-18 4 P 0 13141 1.15 A 326592 D Common Stock 2022-08-18 4 P 0 400 1.14 A 326992 D Common Stock 2022-08-18 4 P 0 1000 1.43 A 5500 I As trustee Stock Option (right to buy) 3.74 2019-11-16 2025-11-16 Common Stock 50000 50000 D Stock Option (right to buy) 3.29 2020-11-18 2026-11-18 Common Stock 52213 52213 D Represents shares of Common Stock held by trusts for the benefit of the Reporting Person's family, of which the Reporting Person is a trustee. The Reporting Person has sole voting and dispositive power with respect to such shares of Common Stock. The Reporting Person disclaims any pecuniary interest in such shares of Common Stock. The Reporting Person was granted 50,000 Stock Options on November 16, 2018 under the Company's Amended and Restated Stock Option Plan (the "Option Plan"). One-hundred percent of the Stock Options have vested. The Reporting Person was granted 52,213 Stock Options on November 18, 2019 under the Option Plan. Sixty-seven percent of the Stock Options have vested. The remaining 33% will vest on November 18, 2022. /s/ Thomas P. Conaghan, Attorney-in-Fact 2022-08-22